CTLA4 and neuroblastoma: In addition to GBM, studies have shown that a common, refractory pediatric cancer called neuroblastoma is sensitive to a combination of Prussian blue nanoparticles (PBNP) photothermotherapy (PTT) and anti-CTLA-4 checkpoint inhibitors.